Search

Author/Creator Song, X.

1. 165P Efficacy and safety of tislelizumab (TIS) plus lenvatinib (LEN) as first-line treatment in patients (pts) with unresectable hepatocellular carcinoma (uHCC): A single-arm, multicenter, phase II trial. (December 2022)

Authors:
Xu, L.; Chen, J.; Yang, J.; Gong, W.; Zhang, Y.; Zhao, H.; Yan, S.; Jia, W.; Wu, Z.; Liu, C.; Song, X.; Ma, Y.; Yang, X.; Gao, Z.; Zhang, N.; Zheng, X.; Li, M.; Zhang, X.; Chen, M.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 203 Population pharmacokinetics of MEDI4736, a fully human antiprogrammed death ligand 1 (PD-L1) monoclonal antibody, in patients with advanced solid tumors. (September 2015)

Authors:
Song, X.; Pak, M.; Chavez, C.; Liang, M.; Lu, H.; Blake-Haskins, A.J.; Robbins, P.B.; Jin, X.; Gupta, A.; Roskos, L.; Narwal, R.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S28
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. A single‐column model ensemble approach applied to the TWP‐ICE experiment. Issue 12 (24th June 2013)

Authors:
Davies, L.; Jakob, C.; Cheung, K.; Genio, A. Del; Hill, A.; Hume, T.; Keane, R. J.; Komori, T.; Larson, V. E.; Lin, Y.; Liu, X.; Nielsen, B. J.; Petch, J.; Plant, R. S.; Singh, M. S.; Shi, X.; Song, X.; Wang, W.; Whitall, M. A.; Wolf, A.
Journal:
Journal of geophysical research
Issue:
Volume 118:Issue 12(2013:Dec.)
Page Start:
6544
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗